Group items tagged

A new compound, discovered jointly by international pharmaceutical company Servier, headquartered in France, and Vernalis (R&D), a company based in the UK, has been shown by researchers at the Walter and Eliza Hall Institute and Servier to block a protein that is essential for the sustained growth of up to a quarter of all cancers.

A link has been made between sleep apnoea - which is often indicated by loud snoring - and worse cancer outcomes in recent studies.

A newly developed vaccine that researchers hope will prove effective at destroying tumors in cases where all other treatments have failed is currently being trialed in the UK.